Healthcare

This bill allows doctors in West Virginia to legally prescribe, distribute, and market specific forms of psilocybin once the FDA approves it and the DEA reschedules it. It amends state pharmacy laws to remove barriers for FDA-approved crystalline polymorph psilocybin products, aligning state regulations with federal decisions. The law applies only to pharmaceutical compositions of psilocybin that meet federal approval standards, not to raw or unapproved forms of the substance. Healthcare providers and pharmacies would be able to handle these medications under existing prescription drug frameworks once federal requirements are met.

HB 5260 adds "edible" as an allowable form of medical cannabis in West Virginia, with strict requirements for safety and regulation. It requires processors to obtain bureau approval for each edible product, mandates specific shapes (like squares or circles), limits edibles to lozenges or gelatins, and caps THC content at 10mg per serving with a 15% potency variance. The bill prohibits color additives in edibles and requires all medical cannabis dispensing to be reported to the state's controlled substance monitoring database. This directly affects patients using medical cannabis, caregivers, and licensed processors who must comply with these new edible-specific rules.